Empfohlen
Weitere ähnliche Inhalte
Andere mochten auch
Healthcare Investment Marketplace
- 1. Diabetic Nephropathy Diabetic Retinopathy Hypercholesterolemia Oral Mucositis Gout Acute Lymphocytic Leukemia Bone Metastasis Brain Cancer Breast Cancer Cervical Cancer Chronic Lymphocytic Leukemia Endometrial Cancer Ewing Sarcoma Gastric Cancer Gastrointestinal Stromal Tumors Head And Neck Cancer Hodgkin Lymphoma Kidney Cancer Liver Cancer Malignant Mesothelioma Medullary Thyroid Cancer Melanoma Multiple Myeloma Non-Hodgkin Lymphoma Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Testicular Cancer Thyroid Cancer Age Related Macular Degeneration Keratoconjunctivitis sicca (Dry Eye) Retinal Vein Occlusion Acute Respiratory Distress Syndrome Sepsis Staphylococcal Infections Acute Coronary Syndrome Angina Pectoris Atrial Fibrillation Coronary Artery Disease (CAD) Critical Limb Ischemia Hypertension Pulmonary Arterial Hypertension Acute Pain Anxiety Disorders Chronic Pain Dementia Diabetic Neuropathy Obsessive-Compulsive Disorder Osteoarthritis Pain Parkinson's Disease Post-Traumatic Stress Disorder Restless Legs Syndrome Schizophrenia Traumatic Brain Injury Liver Cirrhosis Childhood Enuresis Growth Hormone Disorders Hyperparathyroidism Hyperthyroidism Guillain-Barre Syndrome Cytomegalovirus Fungal Infections Gram-Negative Bacterial Infections H1N1 Infection Herpes Zoster HIV-1 Infection Human Papillomavirus Infections Staphylococcus Aureus (MRSA) Cardiovascular Devices Prosthetic Heart Valve Peripheral Vascular Devices Cardiovascular Monitoring & Diagnostic Devices Cardiovascular Surgery Cardiac Rhythm Management Cardiovascular Prosthetic Devices Interventional Cardiology Cardiac Assist Devices Wound Care Management Hospital Supplies Syringes and Needles Disposable Hospital & Surgical Supplies Drug Delivery Devices Inhalation Systems Needle Free Injections Infusion Systems Diabetes Care Devices Insulin Delivery & Glucose Monitoring Ophthalmic Devices Cataract Surgery Devices Ophthalmic Diagnostic Equipment Refractive Surgery Devices ENT Devices Hearing Implants Diagnostic Devices Electrosurgical Devices Dental Equipment & Accessories Diagnostic Imaging & MRI Systems C/T Systems & Mammography Equipment X-Ray & Ultrasound Systems Nuclear Imaging Equipment Contrast Media Injectors Bone Densitometry Anesthesia and Respiratory Devices Anesthesia Machines & Disposables Respiratory Devices & Disposables Sleep Apnea Diagnostic Systems Healthcare IT Medical Imaging Information Systems Nephrology and Urology Devices Renal Dialysis Equipment Orthopedic Devices Orthobiologics & Arthroscopy Joint Reconstruction Trauma Fixation Orthopedic Prosthetics Cranium Maxillofacial Fixation (CMF) Spinal Surgery Endoscopy Devices & instruments Rigid & Flexible Endoscope In Vitro Diagnostics Genetic Testing Clinical Chemistry Hematology Immuno Chemistry Infectious Immunology Histology And Cytology Patient Monitoring Multiparameter Patient Monitoring Micro-Electromechanical Systems Non-invasive Blood Pressure Monitors Neurology Devices Neurostimulation Devices Interventional Neurology CSF Management Neurosurgical Products Radiosurgery Value to the Company
- 2. Healthcare’s Investment Marketplace Discovery Develop- ment I N D PhaseI PhaseII PhaseIII N D A Approval Launch Growth Mature Healthcare Development & Financing Cycle IPO / Public MarketsVenture CapitalAngels / Founders Private Equity / M&A SEED EXIT … E M E R G I N G G R O W T H C O M PA N I E S … ‘ L E A D ’ I N V E S T O R S … D I R E C T I N V E S T O R S … S T R AT E G I C PA RT N E R S & B U Y E R S T R A N S F O R M I N G H E A LT H C A R E C A P I TA L M A R K E T S on behalf of…
- 3. Healthcare’s Investment Marketplace HealthiosXchange 12,000 Investors Across (10) Asset Classes in (37) Countries & 2,000 Strategics in (46) Market sectors “Seed-to-Exit” Direct/Diversified Investment NO Adverse Selection Messaging & Notifications Ratings & Reviews Rules-Based Deal Flow Prediction & Sentiment Data Proprietary Events (6,000)+ Growth Companies NO Fee NO Carry Shorter “Exit” Horizons Real-Time Valuations & Research Less Correlation Reporting & Communications Zero Un-Invested Capital PREMIER POSITIONING EXPANDED ACCESS TO CAPITAL GREATER CERTAINTY ESTABLISHED “EXIT” PATHWAY SUPERIOR OUTCOMES
- 4. Healthcare’s Investment Marketplace Premiere Financing & Strategic Positioning 12,000 Investors Across (10) Asset Classes in (37) Countries & 2,000 Strategics in (46) Market sectors “Seed-to-Exit” Direct/Diversified Investment NO Adverse Selection Messaging & Notifications Ratings & Reviews Rules-Based Deal Flow Prediction & Sentiment Data Proprietary Events (6,000)+ Growth Companies NO Fee NO Carry Shorter “Exit” Horizons Real-Time Valuations & Research Less Correlation Reporting & Communications Zero Un-Invested Capital
- 5. Healthcare’s Investment Marketplace Expanded Access to Capital 12,000 Investors Across (10) Asset Classes in (37) Countries & 2,000 Strategics in (46) Market sectors “Seed-to-Exit” Direct/Diversified Investment NO Adverse Selection Messaging & Notifications Ratings & Reviews Rules-Based Deal Flow Prediction & Sentiment Data Proprietary Events (6,000)+ Growth Companies NO Fee NO Carry Shorter “Exit” Horizons Real-Time Valuations & Research Less Correlation Reporting & Communications Zero Un-Invested Capital
- 6. Healthcare’s Investment Marketplace Greater Transaction Certainty Ratings & Reviews Trending & Following Matching & Targeting Geo-Location
- 7. Healthcare’s Investment Marketplace Established Financing & “Exit” Pathways STRATEGIC PARTNERS & BUYERS INSTITUTIONAL INVESTORS
- 8. Healthcare’s Investment Marketplace Superior Outcomes SUPERIOR OUTCOMES 12,000 Investors Across (10) Asset Classes in (37) Countries & 2,000 Strategics in (46) Market sectors “Seed-to-Exit” Direct/Diversified Investment NO Adverse Selection Messaging & Notifications Ratings & Reviews Rules-Based Deal Flow Prediction & Sentiment Data Proprietary Events (6,000)+ Growth Companies NO Fee NO Carry Shorter “Exit” Horizons Real-Time Valuations & Research Less Correlation Reporting & Communications Zero Un-Invested Capital
Hinweis der Redaktion
- All-at-once, the global healthcare industry is the most complex, chaotic, compelling and dynamic market in the world. A $3 trillion global industry, growing 16% annually, capitalizing itself $13.8 million at a time through more than 9,000 negotiated transactions in 6,000 companies into which, on average, $49 million of capital is deployed over 6.2 years, yielding a “Cash-on-Cash” returns of 4.1x and IRR’s of 22.1% while generating 81% liquidity on invested capital through 892 “Exit” events, of which 87% are M&A. HealthiosXchange is the premier capital marketplace dedicated exclusively to the global healthcare industry. By aggregating 6,000 Emerging Growth healthcare companies in (37) countries together with 30,000 investors in (10) asset classes and 2,000 strategic partners representing (46) market sectors IN A SINGLE MARKET ENVIRONMENT, HealthiosXchange represents a universal capital markets experience perfectly reflective of the industry it serves. We intend to transform the manner in which capital is invested – and value is realized – throughout the global healthcare industry, by serving the needs of: The most promising Emerging Growth Companies in the world The most successful Lead Investors The most active Direct Investors The most competitive Strategic Partners & Buyers
- HealthiosXchange seeks to be the premier healthcare capital market in the world, by transforming the manner in which capital is invested – and value is realized – throughout the global healthcare industry. We intend to achieve this goal by enabling Emerging Growth healthcare companies to: Achieve premier positioning vis-à-vis an EcoSystem of peer companies, investors, and strategic buyers throughout the global healthcare industry Expand access to capital Achieve greater certainty of financing and strategic transactions throughout the development pathway Confirming “Exit” pathways Generate superior shareholder outcomes
- The cornerstone of the HealthiosXchange experience for Emerging Growth healthcare companies is the Xchange listing. Every Company on HealthiosXchange enjoys their own, customized profile, permitting them to: Perfect the Company’s financing and strategic message Reinforce its positioning with current investors, Board of Directors, Key Opinion Leaders and affiliates Establish its market presence among the Company’s emerging growth Peers Maximize awareness of the Company among an EcoSystem of the most active investors and strategic partners in its sector
- Listed on HealthiosXchange are more than 30,000 healthcare investors in (37) countries, segregated in (10) discrete asset classes, along with more than 2,000 strategic buyers in (46) market categories. Among the listed investors are: 3,700 Family Offices 2,100 Alternative Direct Investors 1,300 “Cross-Over” Investors 18,000 Registered Investment Advisors 137 Private Banks 212 Foreign Trusts 29 Sovereign Wealth Organizations Through this global footprint, HealthiosXchange is building the most comprehensive universe of active healthcare investors in the world. This capital markets presence represents an important resource for Emerging Growth healthcare companies to ensure continuous, efficient and cost effective access to capital throughout their lifetime.
- HealthiosXchange offers the most advanced technology to permit Emerging Growth healthcare companies to: Establish a foundation of support from current investors, Board Members, Key Opinion Leaders, and market participants Generate confidence in the Company by accelerating trending momentum within a sector EcoSystem comprised of its peers, partners and prospective investors Expand financing and strategic alternatives by matching preferences and targeting investors in (37) countries Confirm the commitment of strategic sponsors by showcasing the Company in Ratings, Review & “Shark Tank” events By enhancing the certainty of financing and strategic success over the entire lifetime of the Company, HealthiosXchange provides extraordinary value which can alter the risk – return profile of an investment.
- In recognition of the importance of institutional investment and strategic activity in ensuring vibrant, dynamic and efficient capital markets throughout the global healthcare industry, the HealthiosXchange has been designed to engage the most important institutional investors and strategic partners in the world in achieving their own investment objectives and competitive priorities: IN A SINGLE MARKET ENVIRONMENT, HealthiosXchange provides a forum in which 30,000 investors across (10) asset classes and 2,000 strategic partners representing (46) market sectors can interact with 6,000 Emerging Growth healthcare companies in (37) countries. Over the course of the financing, development and “Exit” horizon, this dynamic provides extraordinary confidence and visibility to Emerging Growth healthcare companies. .
- HealthiosXchange provides Emerging Growth healthcare companies with the resources necessary to optimize financing and strategic success. In addition, innovative investment structures and unique capital allocation techniques provide important incentives for capital to become invested.